Window of treatment initiation for human brucellosis, implications for treatment efficacy, and prevention of chronic infection

Clin Infect Dis. 2013 May;56(9):1350-2. doi: 10.1093/cid/cit014. Epub 2013 Jan 16.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / administration & dosage*
  • Brucellosis / drug therapy*
  • China
  • Humans
  • Streptomycin / administration & dosage
  • Tetracycline / administration & dosage
  • Time Factors
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Tetracycline
  • Streptomycin